Combined prevention for persons who inject drugs in the HIV epidemic in a transitional country: the case of Tallinn, Estonia

References

• Abel-Ollo, K., Rahu, M., Rajaleid, K., Talu, A., Rüütel, K., Platt, L., … Uuskula, A. (2009). Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia. AIDS Care, 21, 851–857. doi:10.1080/09540120802657522
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., & Friedman, S. R. (2011). HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. Substance Use & Misuse, 46(2–3), 131–139. doi:10.3109/10826084.2011.521456
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., McKnight, C., Hagan, H., Perlman, D. C., Torian, L. V., … Friedman, S. R. (2010). HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: The importance of transmission behaviors. Drug and Alcohol Dependence, 109, 154–160. doi:10.1016/j.drugalcdep.2009.12.028
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Feelemyer, J. P., Modi, S. N., Abdul-Quader, A., & Hagan, H. (2013). High coverage needle/syringe programs for people who inject drugs in low and middle income countries: A systematic review. BMC Public Health, 19, 13–53.
   Google Scholar
• Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Beatrice, S., Milliken, J., … Friedman, S. R. (2005). HIV incidence among injection drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services. American Journal of Public Health, 95, 1439–1444. doi:10.2105/AJPH.2003.036517
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T. E., Stimson, G. V., Poznyak, V., & WHO Phase II Drug Injection Collaborative Study Group. (2006). Using standardized methods for research on HIV and injecting drug use in developing/transitional countries: Case study from the WHO Drug Injection Study Phase II. BMC Public Health, 6(1), 54. doi:10.1186/1471-2458-6-54
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Pinkerton, S., Hagan, H., Guardino, V., Feelemyer, J., Cooper, H., … Uusküla, A. (2013). 30 years on selected issues in the prevention of HIV among persons who inject drugs. Advances in Preventive Medicine doi:10.1155/2013/346372
   PubMedGoogle Scholar
• Drew, R., Donoghoe, M., Koppel, A., Laukamm-Josten, U., Politi, C., Rotberga, S., … Stöver, H. (2008). Evaluation of fighting HIV/AIDS in Estonia. Retrieved from http://www.euro.who.int/__data/assets/pdf_file/0009/97794/E91264.pdf
   Google Scholar
• Elovich, R., & Drucker, E. (2008). On drug treatment and social control: Russian narcology's great leap backwards. Harm Reduction Journal, 5, 23. doi:10.1186/1477-7517-5-23
   PubMed Web of Science ®Google Scholar
• Estonian Health Board. (2012). HIV/AIDS in Estonia. Retrieved from http://www.terviseamet.ee/nakkushaigused/nakkushaigustesse-haigestumine/hiv-ja-aids.html
   Google Scholar
• Estonian Ministry of Social Affairs. (2012). “Riikliku HIV/AIDSi strateegia aastateks 2006–2015” 2011.aasta tegevusaruanne [The National HIV/AIDS strategy for 2006–2015. Report from year 2011]. Retrieved from http://www.sm.ee/fileadmin/meedia/Dokumendid/Tervisevaldkond/Tervisepoliitika/HIV_AIDS/Strateegia_t%C3%A4itmise_aruanne.pdf
   Google Scholar
• European AIDS Clinical Society (EACS). (2012). Guidelines, n version 5-4 clinical management and treatment of HIV-infected adults in Europe. Retrieved from http://www.europeanaidsclinicalsociety.org/Guidelines/G1_p16.htm
   Google Scholar
• European Centre for Disease Prevention and Control (ECDC). (2009). HIV/AIDS surveillance in Europe, 2008. Retrieved from http://ecdc.europa.eu/en/publications/Publications/0912_SUR_HIV_AIDS_surveillance_in_Europe.pdf
   Google Scholar
• European Centre for Disease Prevention and Control (ECDC). (2012). HIV/AIDS surveillance in Europe, 2011. Retrieved from http://ecdc.europa.eu/en/publications/publications/20121130-annual-hiv-surveillance-report.pdf
   Google Scholar
• The Global Fund to Fight AIDS, Tuberculosis and Malaria. (2007). Project “scaling up the response to HIV in Estonia”. Retrieved from http://portfolio.theglobalfund.org/Grant/Index/EST-202-G01-H-00?lang=en
   Google Scholar
• Gowing, L., Farrell, M. F., Bornemann, R., Sullivan, L. E., & Ali, R. (2011). Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews, 8, CD004145. doi:10.1002/14651858.CD004145.pub4
   Google Scholar
• Kaplan, E. H. (1989). Needles that kill: Modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. Reviews of Infectious Diseases, 11, 289–298. doi:10.1093/clinids/11.2.289
   PubMedGoogle Scholar
• Kaplan, E. H., & O'Keefe, E. (1993). Let the needles do the talking! Evaluating the New Haven needle exchange. Interfaces, 23(1), 7–26.
   Web of Science ®Google Scholar
• MacArthur, G. J., Minozzi, S., Martin, N., Vickerman, P., Deren, S., Bruneau, J., … Hickman, M. (2012). Opiate substitution treatment and HIV transmission in people who inject drugs: Systematic review and meta-analysis. BMJ, 345, e5945. doi:10.1136/bmj.e5945
   PubMed Web of Science ®Google Scholar
• Malekinejad, M., Johnston, L. G., Kendall, C., Kerr, L. R., Rifkin, M. R., & Rutherford, G. W. (2008). Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: A systematic review. AIDS and Behavior, 12(Suppl. 4), S105–S130. doi:10.1007/s10461-008-9421-1
   PubMed Web of Science ®Google Scholar
• Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., … Mattick, R. P. 2007 Reference Group to the UN on HIV and Injecting Drug Use. (2008). Global epidemiology of injecting drug use and HIV among people who inject drugs: A systematic review. Lancet, 372, 1733–1745. doi:10.1016/S0140-6736(08)61311-2
   PubMed Web of Science ®Google Scholar
• Montaner, J. S., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., … Kendall, P. (2014). Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: The “HIV Treatment as Prevention” experience in a Canadian setting. PLoS One, 9(2), e87872. doi:10.1371/journal.pone.0087872
   Google Scholar
• National Institute for Health Development (NIHD), Estonia. (2012). Health promotion and disease prevention: HIV/AIDS. Retrieved from http://www.sm.ee/tegevus/tervis/tervislik-eluviis-ja-haiguste-ennetamine/hivaids.html
   Google Scholar
• Pinkerton, S. D. (2010). Is Vancouver Canada's supervised injection facility cost-saving? Addiction, 105, 1429–1436. doi:10.1111/j.1360-0443.2010.02977.x
   PubMed Web of Science ®Google Scholar
• Pinkerton, S. D. (2011). How many infections are prevented by Vancouver Canada's supervised injection facility? International Journal on Drug Policy, 22, 179–183. doi:10.1016/j.drugpo.2011.03.003
   PubMed Web of Science ®Google Scholar
• Platt, L., Bobrova, N., Rhodes, T., Uusküla, A., Parry, J. V., Rüütel, K., … Judd, A. (2006). High HIV prevalence among injecting drug users in Estonia: Implications for understanding the risk environment. AIDS, 20, 2120–2123. doi:10.1097/01.aids.0000247586.23696.20
   PubMed Web of Science ®Google Scholar
• Rüütel, K., Trummal, A., Salekesin, M., & Pervilhac, C. (2011). Estonia: Analysis of strategic information. Case study. Retrieved from http://www.euro.who.int/__data/assets/pdf_file/0020/155630/e96096.pdf
   Google Scholar
• Statistics Estonia. (2012). Estonia: Population. Retrieved from http://pub.stat.ee/px-web.2001/dialog/statfile1.asp
   Google Scholar
• Uusküla, A., Des Jarlais, D. C., Kals, M., Rüütel, K., Abel-Ollo, K., Talu, A., & Sobolev, I. (2011). Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia. BMC Public Health, 11, 517. doi:10.1186/1471-2458-11-517
   PubMed Web of Science ®Google Scholar
• Uusküla, A., Kals, M., Rajaleid, K., Abel, K., Talu, A., Rüütel, K., … DesJarlais, D. C. (2008). High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: Need for large scale prevention programs. Journal of Public Health (Oxford), 30(2), 119–125. doi:10.1093/pubmed/fdn014
   PubMed Web of Science ®Google Scholar
• Uusküla, A., Laisaar, K.-T., Raag, M., Šmidt, J., Semjonova, S., Kogan, J., … Dehovitz, J. (2012). Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia. AIDS Care, 24, 1470–1479. doi:10.1080/09540121.2012.672724
   PubMed Web of Science ®Google Scholar
• Uusküla, A., McMahon, J. M., Kals, M., Talu, A., Abel-Ollo, K., Rüütel, K., & Des Jarlais, D. C. (2013). Risk for heterosexual HIV transmission among non-injecting female partners of injection drug users in Estonia. AIDS and Behavior, 17, 879–888. doi:10.1016/j.drugpo.2012.11.002
   PubMed Web of Science ®Google Scholar
• Uusküla, A., Rajaleid, K., Talu, A., Abel-Ollo, K., & Des Jarlais, D. C. (2013). A decline in the prevalence of injecting drug users in Estonia, 2005–2009. International Journal on Drug Policy, 24, 312–318. doi:10.1016/j.drugpo.2012.11.002
   PubMed Web of Science ®Google Scholar
• Vorobjov, S., Uusküla, A., Abel-Ollo, K., Talu, A., Rüütel, K., & Des Jarlais, D. C. (2009). Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia. Harm Reduction Journal, 20, 6–3. doi:10.1186/1477-7517-6-3
   Web of Science ®Google Scholar
• de Vos, A. S., van der Helm, J. J., Matser, A., Prins, M., & Kretzschmar, M. E. (2013). Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction? Addiction, 108, 1070–1081.
   Google Scholar
• Wilson, T. E., Sharma, A., Zilmer, K., Kalikova, N., & Uusküla, A. (2007). The HIV prevention needs of injection drug users in Estonia. International Journal of STD and AIDS, 18, 389–391. doi:10.1258/095646207781024900
   PubMed Web of Science ®Google Scholar